osaühing TBD PharmatechRegistered
Key figures
5 116 467 €−18,6%
Revenue 2025
+7,8%
Average annual growth 2019–2025
Ratios
20259,8%
Profit margin
15,6%
EBITDA margin
60,0%
Equity ratio
3,8×
Current ratio
7,3%
Return on equity
2719 €
Average gross salary
Balance sheet structure
Current assetsNon-current assetsLiabilitiesEquity
Quarterly figures
| Quarter | Revenue | Number of employees | Labour taxes |
|---|---|---|---|
| Q2 2026 | 1 670 268 € | 63 | 277 947 € |
| Q1 2026 | 806 286 € | 65 | 266 694 € |
| Q4 2025 | 920 165 € | 64 | 335 152 € |
| Q3 2025 | 2 096 033 € | 67 | 301 460 € |
| Q2 2025 | 861 235 € | 67 | 260 572 € |
| Q1 2025 | 1 926 458 € | 59 | 289 193 € |
Source: Tax Board open data — based on VAT returns, may not exactly match revenue in the annual report. Updated quarterly.
Summary of financial statements2019–2025
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| Balance sheet — assets | |||||||
| Total current assets | 1 517 804 | 2 660 699 | 3 387 676 | 4 436 335 | 3 869 498 | 4 813 768 | 2 934 029 |
| Total non-current assets | 919 322 | 1 234 477 | 1 963 862 | 1 529 432 | 1 657 623 | 6 917 789 | 8 445 524 |
| Total assets | 2 437 126 | 3 895 176 | 5 351 538 | 5 965 767 | 5 527 121 | 11 731 557 | 11 379 553 |
| Balance sheet — liabilities and equity | |||||||
| Current liabilities | 375 786 | 363 839 | 527 799 | 907 270 | 647 501 | 1 401 262 | 771 923 |
| Non-current liabilities | — | — | — | — | — | 4 000 000 | 3 777 772 |
| Total liabilities | 375 786 | 363 839 | 527 799 | 907 270 | 647 501 | 5 401 262 | 4 549 695 |
| Share capital | 7136 | 7136 | 7136 | 7136 | 7136 | 7136 | 7136 |
| Retained earnings of previous periods | 569 486 | 1 515 555 | 2 985 552 | 4 277 954 | 4 513 276 | 4 333 835 | 5 784 510 |
| Profit for the year | 946 069 | 1 469 997 | 1 292 402 | 234 758 | −179 441 | 1 450 675 | 499 563 |
| Reserves and other equity | 538 649 | 538 649 | 538 649 | 538 649 | 538 649 | 538 649 | 538 649 |
| Total equity | 2 061 340 | 3 531 337 | 4 823 739 | 5 058 497 | 4 879 620 | 6 330 295 | 6 829 858 |
| Income statement | |||||||
| Sales revenue | 3 255 697 | 4 568 917 | 4 841 495 | 5 168 441 | 4 115 740 | 6 286 179 | 5 116 467 |
| Operating profit | 946 592 | 1 458 591 | 1 283 899 | 232 329 | −212 477 | 1 435 811 | 612 846 |
| EBITDA | 1 061 870 | 1 615 549 | 1 480 049 | 449 896 | 2144 | 1 625 651 | 799 811 |
| Profit before income tax | 946 069 | 1 469 997 | 1 292 402 | 234 758 | −179 441 | 1 450 675 | 499 563 |
| Profit for the reporting year | 946 069 | 1 469 997 | 1 292 402 | 234 758 | −179 441 | 1 450 675 | 499 563 |
| Labour costs | 922 355 | 1 258 223 | 1 492 396 | 1 825 321 | 2 159 112 | 2 400 332 | 2 699 686 |
| Depreciation of non-current assets | 115 278 | 156 958 | 196 150 | 217 567 | 214 621 | 189 840 | 186 965 |
| Other indicators | |||||||
| Employees | 35 | 44 | 48 | 60 | 58 | 58 | 62 |
| Calculated dividend | — | 0 | 0 | 0 | 0 | 0 | 0 |
A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.
Connections graph
Click a node to see its other connections.
CompanyPersonShareholderOther roleAdditional link
Annual reportsPDF, XBRL
Loading list of reports…
Source: e-Business Register (RIK). Files open/download directly from the official register.
Related companies
Same activity — Põhifarmaatsiatoodete tootmine